In Vitro and In Vivo Functions of SARS-CoV-2 Infection-Enhancing and Neutralizing Antibodies

By
Justin.choi
-
0
269
Scientists isolated neutralizing antibodies against the receptor-binding domain (RBD) and the N-terminal domain (NTD) of SARS-CoV-2 spike from individuals with acute or convalescent SARS-CoV-2 or a history of SARS-CoV infection.
[Cell]
Li, D., Edwards, R. J., Manne, K., Martinez, D. R., Schäfer, A., Alam, S. M., Wiehe, K., Lu, X., Parks, R., Sutherland, L. L., Oguin, T. H., McDanal, C., Perez, L. G., Mansouri, K., Gobeil, S. M. C., Janowska, K., Stalls, V., Kopp, M., Cai, F., … Saunders, K. O. (2021). In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell, 0(0). https://doi.org/10.1016/j.cell.2021.06.021 Cite
AbstractFull Article